Technical Analysis for PTGX - Protagonist Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Multiple of Ten Bullish | Other | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| New Downtrend | Bearish | 5.17% | |
| Expansion Breakdown | Bearish Swing Setup | 5.17% | |
| 200 DMA Support | Bullish | 5.17% | |
| Lizard Bullish | Bullish Day Trade Setup | 5.17% | |
| Volume Surge | Other | 5.17% | |
| Wide Range Bar | Range Expansion | 5.17% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | about 20 hours ago |
| Lizard Bullish Entry | about 20 hours ago |
| Rose Above Previous Day's High | about 20 hours ago |
| Up 3% | about 20 hours ago |
| Down 2 % | about 20 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 10/31/2024
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The Company's initial lead product candidates consists of PTG-100 and PTG-200, which have the potential to transform the existing treatment paradigm for inflammatory bowel disease, a GI disease consisting primarily of ulcerative colitis and Crohn's disease; PTG-300, an injectable hepcidin mimetic. Protagonist Therapeutics, Inc. is based in Milpitas, United States.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Immunology Autoimmune Disease Inflammatory Bowel Disease Ulcerative Colitis Ulcer Abdominal Pain Colitis Crohn's Disease Chemical Entities Hepcidin
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Immunology Autoimmune Disease Inflammatory Bowel Disease Ulcerative Colitis Ulcer Abdominal Pain Colitis Crohn's Disease Chemical Entities Hepcidin
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 48.89 |
| 52 Week Low | 16.8 |
| Average Volume | 677,503 |
| 200-Day Moving Average | 35.71 |
| 50-Day Moving Average | 45.34 |
| 20-Day Moving Average | 44.97 |
| 10-Day Moving Average | 42.80 |
| Average True Range | 2.41 |
| RSI (14) | 36.31 |
| ADX | 30.0 |
| +DI | 11.32 |
| -DI | 40.54 |
| Chandelier Exit (Long, 3 ATRs) | 41.66 |
| Chandelier Exit (Short, 3 ATRs) | 40.54 |
| Upper Bollinger Bands | 51.02 |
| Lower Bollinger Band | 38.92 |
| Percent B (%b) | 0.14 |
| BandWidth | 26.90 |
| MACD Line | -1.49 |
| MACD Signal Line | -0.68 |
| MACD Histogram | -0.8105 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 45.73 | ||||
| Resistance 3 (R3) | 45.34 | 43.26 | 44.88 | ||
| Resistance 2 (R2) | 43.26 | 41.97 | 43.45 | 44.60 | |
| Resistance 1 (R1) | 41.96 | 41.17 | 42.61 | 42.34 | 44.32 |
| Pivot Point | 39.88 | 39.88 | 40.20 | 40.07 | 39.88 |
| Support 1 (S1) | 38.57 | 38.58 | 39.22 | 38.96 | 36.98 |
| Support 2 (S2) | 36.49 | 37.78 | 36.68 | 36.70 | |
| Support 3 (S3) | 35.19 | 36.49 | 36.42 | ||
| Support 4 (S4) | 35.57 |
